- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Jubilant Pharmova Limited — Board Meeting, 06-02-2026: Outcome of Board Meeting
06-02-2026 | 12:40 pm
06-02-2026 | 12:40 pm
Jubilant Pharmova's Board approved consolidated financial results for the quarter & nine months ended Dec 31, 2025. Revenue reached ₹2,122.5 Cr, with Net Profit at ₹55.8 Cr.
No comments yet. Be the first to comment!